ChronicVent Opportunity The Avery Diaphragm Pacemaker addresses chronic ventilatory support for patients with upper motor neuron respiratory muscle paralysis or CAH, presenting a compelling alternative to mechanical ventilation that could expand an account base among hospitals and clinics serving spinal cord injury, neuromuscular, and centerless care facilities.

PediatricFocus Potential With indications for both adult and pediatric patients, there is a pathway to engage pediatric centers and ventillation specialists who treat congenital Central Hypoventilation Syndrome and other pediatric ventilation needs, expanding the addressable market.

CostSavings Angle Promote long-term reliability and reduced infection risk as cost-reducing and quality-of-life benefits to payers and procurement teams, positioning the product as a value-based alternative to ongoing mechanical ventilation and associated healthcare costs.

AwarenessMomentum Recent activity around International CCHS Day indicates alignment with patient advocacy and awareness campaigns; leverage partnerships with advocacy groups and clinical thought leaders to drive case studies, referrals, and trial opportunities.

StrategicOrgTargets Given a revenue range in the low to mid millions and a modest employee base, target mid-sized hospitals, regional medical centers, and specialty clinics with phrenic nerve stimulation or ventilatory support programs, coordinating pilots, training, and reimbursement discussions to accelerate adoption.